Your Body Is Sending Signals: Why Fasting Insulin Is the Test Your Annual Labs Are Missing

There's a number that may matter more for your long-term health than almost anything else on a standard lab panel — and most people have never had it checked. Not once.

It's called fasting insulin, and it's rarely ordered as part of routine care. Not because it isn't useful. Because of how our medical system is built.

A System Built for Sick Care, Not Well Care

Modern medicine is extraordinary at finding, treating, and managing disease once it shows up. What it isn't built for is catching the years of quiet dysfunction that happen before a diagnosis.

Here's the reality of how insurance-based care works: in order for a lab or visit to be covered, it has to be tied to a code — usually a diagnosis or a set of symptoms that already exist. In other words, you typically need to already have low vitamin D, already show signs of insulin resistance, or already meet criteria for obesity or diabetes before the system pays attention. We test to confirm what's already happened, rather than to catch what's about to happen.

That's backward. And it's exactly why preventive, proactive testing — the kind that looks for subtle shifts long before symptoms appear — has become the focus of my work. When you test and watch for small changes in the right direction, you stay in control. When you wait for symptoms, the disease is already setting the terms.

The Most Powerful Preventive Marker You've Never Had Drawn

Fasting insulin may be one of the most valuable predictive markers in all of metabolic health — but only if it's measured early enough to matter.

Research shows that elevated fasting insulin and declining insulin sensitivity can appear years before a type 2 diabetes diagnosis. A well-known analysis of the Whitehall II study, which followed over 6,500 adults and identified 505 new diabetes cases, found that significant changes in blood glucose, insulin sensitivity, and insulin secretion occurred 3 to 6 years before diabetes was actually diagnosed. The body had already been compensating, quietly, for years before anyone noticed.

To understand why this matters, it helps to understand what insulin is actually doing.

Think of the insulin receptor on each cell like a locked door. Insulin is the key. When insulin "unlocks" the door, glucose can move out of the bloodstream and into the cell, where it's used for energy. That's the system working as designed.

Now imagine the room behind that door is already full. You can't keep stuffing more into a space that has no room left. When your cells are overloaded — packed with stored fat and fuel they don't need — they start resisting the key. The lock gets stiff. Insulin knocks, but the door doesn't open as easily.

This is insulin resistance: a protective shut-down at the cellular level. And the body's response is to produce more insulin, more key-cutting, more pressure on the lock, just to force the same amount of glucose through. For a while, it works. Blood sugar can stay completely normal while insulin quietly climbs higher and higher in the background to compensate. That compensation is silent. There's no symptom checklist for "your pancreas is working twice as hard as it should." You simply don't feel it — until you do, often as low energy, brain fog, stubborn weight gain (especially around the midsection), or both.

"Blood sugar can stay completely normal while insulin quietly climbs higher and higher in the background to compensate."

Why A1C Alone Isn't Telling You the Full Story

Hemoglobin A1C is the test most people do get drawn yearly. It estimates your average blood sugar over the prior 90 to 120 days, which is roughly the lifespan of a red blood cell. The problem is that it's an average — and averages can hide a lot.

In early metabolic dysfunction, blood sugar often swings widely. You eat a carbohydrate-heavy meal, your pancreas releases a surge of insulin to compensate, and your blood sugar can actually dip lower than normal afterward. High peaks, low valleys — and when you average it out, the A1C can look perfectly fine. You leave your annual physical with a clean bill of health, while underneath, insulin resistance has already been building for years. The body is very, very good at compensating — right up until it isn't.

It's also worth noting that A1C isn't even reliable for everyone: if you're anemic, your A1C can be inaccurate, since the test depends directly on the lifespan and turnover of your red blood cells.

A Tale of Two Patients

Consider two patients with identical fasting glucose (85) and identical A1C (5.4):

• Patient A has a fasting insulin of 3.
• Patient B has a fasting insulin of 20.

On a standard panel, these two people look the same. But they are not the same — not even close. The data tells us Patient A is far more likely to live longer, stay metabolically healthy, and avoid the chronic diseases that come with years of unaddressed insulin resistance. Patient B's body is already working overtime, and nothing on a standard panel would reveal it.

This is the blind spot in only screening with blood sugar and A1C. Fasting insulin is often the earliest and clearest signal — and it's the one we're not checking.

The HOMA-IR: Putting the Pieces Together

When fasting glucose and fasting insulin are drawn at the same time, they can be used to calculate something called the HOMA-IR — a recognized estimate of insulin resistance and metabolic risk. It's a simple, well-established calculation that gives real insight into how hard your body is working to manage blood sugar, long before that effort fails and glucose starts climbing.

Given how common metabolic dysfunction has become — and how much younger the age of diagnosis keeps trending — it's worth asking: why isn't this run on every routine panel?

It's Not Just About Blood Sugar

Insulin doesn't operate in isolation. It's deeply connected to your hormone system as a whole — more like one component in a finely tuned engine than an isolated gauge.

A few connections worth knowing:

• Insulin resistance is linked to elevated reverse T3, which can interfere with healthy thyroid function. If you're being tested or treated for thyroid issues without insulin ever being part of the conversation, that's a missing piece of the puzzle.
• Healthy insulin balance also plays a role in optimizing sex hormones. If you're working with a provider on hormone optimization — including bioidentical hormone therapy — and fasting insulin has never been part of your testing, something important may be getting overlooked.
• The relationship runs both directions, too: declining estrogen has been linked to increased insulin resistance, which is one more reason hormones can't be assessed in silos.
• Other contributors worth knowing about: chronic stress and poor sleep can both raise blood glucose and worsen insulin resistance, even when diet and activity stay consistent.

What Helps

The encouraging part: insulin sensitivity responds well to the right inputs. Some of the most effective levers include:

• Building and maintaining muscle mass
• Walking after meals
• Prioritizing protein at meals
• Eating fresh fruits and vegetables
• Getting 30–50 grams of fiber daily
• Reducing processed foods, added sugars, and refined carbohydrates

A useful general target: fasting insulin under 6, with an optimal range closer to 2–5.

The Investment Either Way

Wellness is an investment. The only real choice is whether you make that investment now, on your own terms, or later, on the disease's terms.

Paying out of pocket for preventive labs can feel like an upfront cost. But it's almost always a smaller one than the cost of catching a problem after it's already taken hold — not just financially, but in energy, quality of life, and the years you get to feel genuinely well in. Most days should feel like good days. That's not an unrealistic standard to hold for yourself.

Your Body Is Already Sending the Signal

Long before any diagnosis, your body is communicating. Rising fasting insulin is one of its clearest early signals — a quiet, measurable sign that something is shifting, well before symptoms or a diagnosis code ever enter the picture.

The only question is whether anyone is listening early enough to catch it.

That's the entire premise behind ClearSignal: in-depth, specialist-led lab review that looks for the signals your body is already sending — so you can act on them, instead of waiting for a diagnosis to do it for you.

Reference: Tabák AG, Jokela M, Akbaraly TN, et al. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet. 2009;373:2215-2221.